• Order Samples & Materials
• Guidelines and Studies
• Patient Education

• Efficacy
• Safety
  • Safety by System
  • Diseases / Conditions
  • Drug Interactions
  • Laboratory Tests
  • Overdose Management
• Pharmacology
• Products & Dosing
• Proper Use

TYLENOL^® Safety Profile

The safety of TYLENOL® at recommended doses, has been established over 50 years of use and scientific investigation. McNeil Consumer Healthcare has studied acetaminophen in over 1500 patients who received recommended daily doses (4 grams) for up to one year. See study

Studies have shown that TYLENOL® (acetaminophen):

• Delivers a superior GI safety profile compared to Rx NSAIDs
• Is less likely to interfere with certain other medications, like those used in antihypertensive therapy
• Does not interfere with low-dose aspirin therapy

Safety in Medically Complex Patients

Even in complex patient cases, TYLENOL® remains the safer choice. Respected medical associations endorse acetaminophen as a first-line analgesia in these populations:

• The National Kidney Foundation, for episodic use in patients with underlying kidney disease
• The American Lung Association, for aches and pains associated with colds and flu
• The American Heart Association, for patients with known cardiovascular disease or risk factors for ischemic heart disease
• The American Geriatrics Society, for mild-to-moderate musculoskeletal pain in people ages 50 and over